Modern Vaccines/Adjuvants Formulation—Session 2 (Plenary II)

Abstract

On the 15–17th May 2013, the Fourth International Conference on Modern Vaccines/Adjuvants Formulation was organized in Lausanne, Switzerland, and gathered stakeholders from academics and from the industry to discuss several challenges, advances and promises in the field of vaccine adjuvants. Plenary session 2 of the meeting was composed of four different presentations covering: (1) the recent set-up of an adjuvant technology transfer and training platform in Switzerland, (2) the proposition to revisit existing paradigms of modern vaccinology, (3) the properties of polyethyleneimine as potential new vaccine adjuvant, and (4) the progresses in the design of HIV vaccine candidates able to induce broadly neutralizing antibodies.

Keywords: :

• vaccine adjuvant
• technology transfer
• HIV vaccine
• cationic polymer
• formulation

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.